These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33993252)

  • 1. HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
    Watera C; Ssemwanga D; Namayanja G; Asio J; Lutalo T; Namale A; Sanyu G; Ssewanyana I; Gonzalez-Salazar JF; Nazziwa J; Nanyonjo M; Raizes E; Kabuga U; Mwangi C; Kirungi W; Musinguzi J; Mugagga K; Mbidde EK; Kaleebu P
    J Antimicrob Chemother; 2021 Aug; 76(9):2407-2414. PubMed ID: 33993252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pretreatment and acquired HIV drug resistance in Nicaragua: results from the first nationally representative survey, 2016.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Román M; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Juárez SI; Ravasi G; Vargas C; Gutiérrez R; Romero L; Solórzano A; Sajquim E; Northbrook S; Ávila-Ríos S; Reyes-Terán G
    J Int AIDS Soc; 2019 Dec; 22(12):e25429. PubMed ID: 31860167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment HIV drug resistance among adults initiating ART in Namibia.
    Taffa N; Roscoe C; Sawadogo S; De Klerk M; Baughman AL; Wolkon A; Mutenda N; DeVos J; Zheng DP; Wagar N; Prybylski D; Yang C; Hamunime N; Agolory S; Raizes E
    J Antimicrob Chemother; 2018 Nov; 73(11):3137-3142. PubMed ID: 30137412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.
    Segujja F; Omooja J; Lunkuse S; Nanyonjo M; Nabirye SE; Nassolo F; Bugembe DL; Bbosa N; Kateete DP; Ssenyonga W; Mayanja Y; Nsubuga RN; Seeley J; Kaleebu P; Ssemwanga D
    AIDS Res Hum Retroviruses; 2020 Sep; 36(9):782-791. PubMed ID: 32475121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of dried blood spot specimens can expedite nationwide surveillance of HIV drug resistance in resource-limited settings.
    Zhang G; DeVos J; Medina-Moreno S; Wagar N; Diallo K; Beard RS; Zheng DP; Mwachari C; Riwa C; Jullu B; Wangari NE; Kibona MS; Ng'Ang'A LW; Raizes E; Yang C
    PLoS One; 2018; 13(9):e0203296. PubMed ID: 30192818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High level of pre-treatment and acquired HIV drug resistance in Honduras: a nationally representative survey, 2016-17.
    Girón-Callejas A; García-Morales C; Mendizabal-Burastero R; Meza RI; Sierra T; Tapia-Trejo D; Pérez-García M; Quiroz-Morales VS; Paredes M; Rodríguez A; Juárez SI; Farach N; Videa G; Lara B; Rodríguez E; Ardón E; Sajquim E; Lorenzana R; Ravasi G; Northbrook S; Reyes-Terán G; Ávila-Ríos S
    J Antimicrob Chemother; 2020 Jul; 75(7):1932-1942. PubMed ID: 32303063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment and Acquired Antiretroviral Drug Resistance Among Persons Living With HIV in Four African Countries.
    Crowell TA; Danboise B; Parikh A; Esber A; Dear N; Coakley P; Kasembeli A; Maswai J; Khamadi S; Bahemana E; Iroezindu M; Kiweewa F; Owuoth J; Freeman J; Jagodzinski LL; Malia JA; Eller LA; Tovanabutra S; Peel SA; Ake JA; Polyak CS;
    Clin Infect Dis; 2021 Oct; 73(7):e2311-e2322. PubMed ID: 32785695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay-Results of a Nationally Representative Survey, 2018-2019.
    Flieller R; Cabrera S; Ruchansky D; Girón-Callejas A; Brasesco M; Pérez D; Chiparelli H; García-Morales C; Tapia-Trejo D; Monreal-Flores J; Ravasi G; Jordan MR; Ávila-Ríos S
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Drug Resistance Among Children Initiating First-Line Antiretroviral Treatment in Uganda.
    Kityo C; Sigaloff KC; Sonia Boender T; Kaudha E; Kayiwa J; Musiime V; Mukuye A; Kiconco M; Nankya I; Nakatudde-Katumba L; Calis JC; Rinke de Wit TF; Mugyenyi PN
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):628-35. PubMed ID: 26723018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.
    Aliyu GG; Lawton JG; Mitchell AB; Abimiku AG; Jelpe T; Bassey O; Riedel DJ; Swaminathan M; Chang JC; DeVos JR; Patel H; Charurat ME; Stafford KA;
    AIDS; 2023 Feb; 37(2):333-339. PubMed ID: 36541644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
    Hamers RL; Wallis CL; Kityo C; Siwale M; Mandaliya K; Conradie F; Botes ME; Wellington M; Osibogun A; Sigaloff KC; Nankya I; Schuurman R; Wit FW; Stevens WS; van Vugt M; de Wit TF;
    Lancet Infect Dis; 2011 Oct; 11(10):750-9. PubMed ID: 21802367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV drug resistance in persons initiating or reinitiating first-line antiretroviral therapy in Paraguay: Results of a National Patient Survey.
    Aguilar G; Truong HM; Ovelar P; Samudio T; Lopez G; García-Morales C; Tapia-Trejo D; López-Sánchez DM; Ávila-Ríos S; Giron A; De Arias AR; Rios-Gonzalez C; McFarland W
    J Med Virol; 2022 Oct; 94(10):5061-5065. PubMed ID: 35701340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 viraemia and drug resistance amongst female sex workers in Soweto, South Africa: A cross sectional study.
    Coetzee J; Hunt G; Jaffer M; Otwombe K; Scott L; Bongwe A; Ledwaba J; Molema S; Jewkes R; Gray GE
    PLoS One; 2017; 12(12):e0188606. PubMed ID: 29244809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.
    Dat VQ; Anh NTL; Van Nghia K; Linh NT; Thu HHK; Tam TTM; Ton T; Anh LQ; Phuc ND; Huong PTT; Nhan DT; Hai NH; Bertagnolio S; Crisp AM; Inzaule S; Dean NE; Jordan MR; Nguyen VTT
    J Int AIDS Soc; 2022 Feb; 25(2):e25857. PubMed ID: 35194954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
    Kaleebu P; Kirungi W; Watera C; Asio J; Lyagoba F; Lutalo T; Kapaata AA; Nanyonga F; Parry CM; Magambo B; Nazziwa J; Nannyonjo M; Hughes P; Hladik W; Ruberantwari A; Namuwenge N; Musinguzi J; Downing R; Katongole-Mbidde E;
    PLoS One; 2015; 10(12):e0145536. PubMed ID: 26700639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment HIV Drug Resistance Among Adults Initiating or Re-Initiating First-Line Antiretroviral Therapy in Zimbabwe: Fast-Tracking the Transition to Dolutegravir-Based First-Line Regimens?
    Kouamou V; Mavetera J; Manasa J; Ndhlovu CE; Katzenstein D; McGregor AM
    AIDS Res Hum Retroviruses; 2021 Oct; 37(10):776-783. PubMed ID: 33430681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the HIV drug resistance surveillance system in Mozambique, 2017-2018.
    Nuvunga S; Langa DC; Baltazar CS; Sacarlal J; Rossetto E; Vubil A
    Pan Afr Med J; 2022; 43():162. PubMed ID: 36825120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia.
    Jordan MR; Hamunime N; Bikinesi L; Sawadogo S; Agolory S; Shiningavamwe AN; Negussie T; Fisher-Walker CL; Raizes EG; Mutenda N; Hunter CJ; Dean N; Steegen K; Kana V; Carmona S; Yang C; Tang AM; Parkin N; Hong SY
    Medicine (Baltimore); 2020 Sep; 99(37):e21661. PubMed ID: 32925712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance survey.
    Kamori D; Barabona G; Rugemalila J; Maokola W; Masoud SS; Mizinduko M; Sabasaba A; Ruhago G; Sambu V; Mushi J; Mgomella GS; Mcollogi JJ; Msafiri F; Mugusi S; Boniface J; Mutagonda R; Mlunde L; Amani D; Mboya E; Mahiti M; Rwebembera A; Ueno T; Pembe A; Njau P; Mutayoba B; Sunguya B
    J Antimicrob Chemother; 2023 Mar; 78(3):779-787. PubMed ID: 36680436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of pretreatment drug resistance in persons initiating and reinitiating antiretroviral therapy in Sri Lanka: results from a national representative survey.
    Elwitigala J; Rajapaksa L; Inzaule SC; Ariyaratne KAM; Jayasena S; Kurle S; Patil A; Kale D; Siriwardna L; Samaraweera G; Perera H; Jayakody C
    J Antimicrob Chemother; 2023 Jun; 78(6):1476-1479. PubMed ID: 37071590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.